-
???insights.card.a11y.category??? news News
Steve Ricchiuto on Bloomberg Surveillance (Starts at 2:06:55)
-
???insights.card.a11y.category??? news News
Top Calls: Zoom's Transition
-
???insights.card.a11y.category??? news News
Dominic Konstam on Bloomberg Surveillance (Starts at 30:23)
-
???insights.card.a11y.category??? news News
Borrowers with student loans average higher incomes, says Mizuho’s Dan Dolev
-
???insights.card.a11y.category??? news News
What pharma brands will be impacted by Medicare price negotiations
-
???insights.card.a11y.category??? news News
Mizuho’s Jared Holz on Novo Nordisk: There’s not much upside near-term
-
???insights.card.a11y.category??? news News
Mizuho gains footing in US mortgage market
-
???insights.card.a11y.category??? news News
Novo Nordisk shares pop after key trial data shows Wegovy cuts risk of heart attack or stroke by 20%
-
???insights.card.a11y.category??? news News
People are ‘scratching and clawing’ for negative narrative around obesity drugs: Mizuho’s Jared Holz